The ethically controversial option of genetic population screening used to be restricted to a small number of rather rare diseases by methodological limitations which are now about to be overcome. With the new technology of DNA microarrays ("DNA chip"), emerging from the synthesis of microelectronics and molecular biology, methods are now at hand for the development of mass screening programmes for a wide spectrum of genetic traits. Thus, the DNA chip may be the key technology for a refined preventive medicine as well as a new dimension of eugenics. The forthcoming introduction of the DNA chip technology into medical practice urgently requires an internationally consistent framework of ethical standards and legal limitations if we do not want it to become a new Pandora's box.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Reproductive carrier screening: responding to the eugenics critique
- Mutation screening for thalassaemia in the Jino ethnic minority population of Yunnan Province, Southwest China
- High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
- The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis
- Consumerism in prenatal diagnosis: a challenge for ethical guidelines
- Mutational analysis using oligonucleotide microarrays
- Importance of genetic screens in precision oncology
- DNA microarrays in medical practice
- Nursing, obedience, and complicity with eugenics: a contextual interpretation of nursing morality at the turn of the twentieth century
- Nutritional genomics